| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.009 |